ISO/TS 22859:2022

Biotechnology — Biobanking — Requirements for human mesenchymal stromal cells derived from umbilical cord tissue

Publication date: Jul 20, 2022

General information

Current stage: 60.60 Effective date: Jul 20, 2022

Originator: ISO

Owner: ISO/TC 276

Type: Technical Specification

ICS: 07.080

Languages: English

Buying

Status: Published

PDF - EC$436.45

Paper - EC$436.45

PDF and Paper - EC$872.90

Language

Language in which you want to receive the document.

Scope

This document specifies requirements for the biobanking of human mesenchymal stromal cells derived from umbilical cord tissue (i.e. Wharton’s jelly), further referred to as hUC-MSCs, including the collection of umbilical cord tissue and associated data, isolation, culture characterization, quality control, cryopreservation, storage, thawing, disposal, distribution and transport.
This document is applicable to all organizations performing biobanking of hUC-MSCs used for research and development.
This document does not apply to hUC-MSCs for the purpose of in vivo application in humans, clinical applications or therapeutic use.
NOTE International, national or regional regulations or requirements, or multiple of them, can also apply to specific topics covered in this document.

Life cycle

NOW

PUBLISHED
ISO/TS 22859:2022
60.60 Standard published
Jul 20, 2022

Preview

Only informative sections of projects are publicly available. To view the full content, you will need to members of the committee. If you are a member, please log in to your account by clicking on the "Log in" button.